分类: health

  • Experts warn against drinking raw milk after New Mexico baby’s listeria death

    Experts warn against drinking raw milk after New Mexico baby’s listeria death

    A tragic infant death in New Mexico has triggered urgent health warnings from medical experts regarding the consumption of unpasteurized raw milk. Health authorities confirmed a newborn succumbed to a listeria infection that was likely transmitted when the mother consumed raw dairy during pregnancy. This fatal case has ignited renewed concerns about the dangerous trend of consuming untreated dairy products.

    The New Mexico Department of Health emphasized that raw milk carries significant pathogen risks including bird flu, brucella, tuberculosis, salmonella, campylobacter, cryptosporidium, and E. coli. Unlike pasteurized milk, which undergoes a heating process to eliminate dangerous bacteria, raw milk comes directly from animals without any pathogen-elimination treatment. Listeria poses particular danger to pregnant women as it can cross the placental barrier, with neonatal infections carrying a 20-30% mortality rate.

    This safety alert emerges alongside developments at Ballerina Farm, a prominent influencer-owned company with over 10 million social media followers, which recently paused raw milk sales following routine testing that revealed health violations. The company’s owner, Hannah Neeleman, had previously promoted raw milk as ‘liquid gold’ on Instagram, claiming skincare benefits and stating her family drinks directly from the cow.

    The raw milk movement has gained momentum through social media influencers and political campaigns such as the Make America Healthy Again (MAHA) movement, which has advocated for legalizing unpasteurized dairy sales. Notably, Health and Human Services Secretary Robert F. Kennedy Jr. has previously identified as a raw milk enthusiast.

    Dr. Kali Kneil, Professor of Microbial Food Safety at the University of Delaware, cautioned that ‘even if it’s a clean dairy, or the animals look healthy, you cannot guarantee that raw milk is clear of pathogens.’ She attributed the trend’s popularity partly to European studies suggesting raw milk might help with asthma and allergies, though she emphasized that pasteurization doesn’t significantly diminish nutritional value while providing crucial protection.

    Health officials are urging state and local governments to follow New Mexico’s lead in warning vulnerable populations—including pregnant women, young children, elderly individuals, and immunocompromised persons—about the serious risks associated with raw dairy consumption.

  • Nestle recalls more Guigoz baby formula as France tightens toxin level

    Nestle recalls more Guigoz baby formula as France tightens toxin level

    In a significant development for infant nutrition safety, Nestle has broadened its recall of Guigoz-brand baby formula products following France’s decision to implement more stringent regulations regarding cereulide toxin levels. This move contradicts earlier analyst predictions that additional withdrawals would be unnecessary.

    The expanded recall comes as detection methods for cereulide—a toxin known to cause nausea, vomiting, and other gastrointestinal symptoms—have become increasingly sophisticated. The contamination originated from ingredients sourced from a Chinese manufacturing facility that supplies multiple major infant formula producers, including industry giants Danone and Lactalis.

    France’s revised safety threshold, established last Saturday, represents a proactive measure to enhance consumer protection amid growing international concern. The decision followed consultations with the European Food Safety Authority (EFSA), which subsequently issued comparable guidance earlier this week.

    Despite assertions from Barclays and Jefferies analysts that Nestle and Danone would likely avoid further recalls, Nestle proceeded with voluntary market withdrawals. This marks the third recall incident since December, when initial contaminations were identified.

    The situation has gained additional gravity as French authorities investigate potential connections between the contaminated products and the tragic deaths of two infants. While both Nestle and French health officials emphasize that no conclusive evidence currently links the formula to these fatalities, results from ongoing investigations are anticipated within days.

    The contamination event has triggered widespread product recalls across dozens of countries, generating substantial concern among parents and caregivers regarding infant nutrition safety standards and international supply chain oversight.

  • Health warning over Cape Verde travel after stomach bug deaths

    Health warning over Cape Verde travel after stomach bug deaths

    The UK Health Security Agency (UKHSA) has escalated travel health advisories for Cape Verde following a significant outbreak of gastrointestinal infections that have affected British tourists. Official data reveals 118 confirmed cases of shigellosis and 43 instances of salmonella poisoning linked to visits to the West African archipelago since October, with four British nationals having died within months of contracting these illnesses during their holidays.

    This health alert emerges strategically ahead of the February half-term break, a period when substantial numbers of UK travelers traditionally seek winter sun in Cape Verde’s typically warm 25°C climate. Both shigella and salmonella are serious bacterial infections targeting the intestinal system, producing severe symptoms including acute diarrhea, high fever, and abdominal cramps. While most healthy individuals recover within several days, vulnerable populations—particularly young children, elderly adults, pregnant women, and immunocompromised individuals—face potentially life-threatening complications.

    Transmission occurs primarily through fecal-oral routes, either via direct person-to-person contact or indirectly through contaminated food, water, or surfaces. UKHSA epidemiological tracing indicates the majority of shigella cases originated from the Santa Maria resort area on Sal Island and Boa Vista, the archipelago’s easternmost island.

    Medical experts emphasize preventive measures including consuming only freshly prepared, thoroughly cooked foods served hot; drinking bottled or boiled water while avoiding ice; using purified water for dental hygiene; personally peeling all fruits; and avoiding salads potentially washed in contaminated water. Dr. Gauri Godbole, UKHSA’s deputy director for gastrointestinal infections, stressed that ‘taking simple precautions against traveler’s diarrhoea can make all the difference,’ highlighting meticulous hand hygiene with soap or alcohol gel as the primary defense mechanism.

    Professor Damien Tully of the London School of Hygiene and Tropical Medicine noted that such outbreaks are ‘not unusual in busy hospitality settings,’ particularly identifying buffet-style catering as potential ‘breeding grounds’ for pathogens.

    The human impact includes four documented British fatalities in 2023: Mark Ashley (55, Bedfordshire), Elena Walsh (64, Birmingham), Karen Pooley (64, Gloucestershire), and an unnamed 56-year-old Watford man. These individuals are among six British tourists who died after vacationing in Cape Verde since January 2023, with all families now pursuing personal injury litigation against package holiday giant Tui. Relatives have reported concerning hygiene standards at resorts, though Tui has acknowledged investigating these claims while refraining from detailed commentary during active legal proceedings.

    Compounding the situation, Hurricane Erin’s August strike damaged critical water and sanitation infrastructure across Cape Verde, prompting World Health Organization assessments warning of elevated disease risks from contaminated water and insect vectors.

  • WHO announces restart of preventive cholera vaccinations after nearly 4-year halt

    WHO announces restart of preventive cholera vaccinations after nearly 4-year halt

    CAPE TOWN — The World Health Organization announced Wednesday the resumption of preventive cholera vaccination initiatives worldwide, marking a pivotal shift from reactive outbreak response to proactive immunization strategies. This development follows the resolution of a severe vaccine shortage that had paralyzed global prevention efforts for nearly four years.

    In a coordinated declaration, WHO alongside GAVI vaccine alliance and UNICEF revealed that the oral cholera vaccine stockpile has rebounded to approximately 70 million doses—a dramatic recovery from the critically low 35 million doses available during the 2022 shortage crisis. The improved supply enables the first preventive allocation of 20 million doses, with Mozambique receiving 3.6 million doses, Congo obtaining 6.1 million, and Bangladesh scheduled for 10.3 million doses.

    WHO Director-General Tedros Adhanom Ghebreyesus emphasized the strategic importance: “Global vaccine shortages previously confined us to merely reacting to cholera outbreaks. We now possess the capacity to break this cycle through preventive vaccination campaigns.”

    The resurgence of cholera—a waterborne diarrheal disease—has been exacerbated by intersecting crises of poverty, conflict, and climate change. Recent devastating floods in Mozambique affecting 700,000 people exemplify how climate-related disasters amplify cholera risks by compromising water sanitation infrastructure and facilitating bacterial spread.

    During the shortage, WHO implemented a single-dose vaccination protocol as an emergency measure. The organization now maintains this single-dose approach as standard practice, while considering two-dose campaigns based on specific epidemiological circumstances.

    Surveillance data reveals concerning trends: 2023 recorded over 600,000 cholera cases and approximately 7,600 fatalities worldwide. While case numbers showed a decline in 2025 after consecutive annual increases since 2021, cholera-related mortality rates continue to climb, underscoring the critical need for sustained preventive measures.

  • CCEOI elevates aesthetic and reconstructive surgery standards in Mauritius region

    CCEOI elevates aesthetic and reconstructive surgery standards in Mauritius region

    After a quarter-century of medical excellence, the Centre de Chirurgie Esthétique de l’Océan Indien (CCEOI) has established itself as a premier destination for comprehensive aesthetic and reconstructive surgery in the Indian Ocean region. Under the leadership of Medical Director Raphael Bax, this Mauritius-based institution has developed an integrated approach that combines surgical expertise, cutting-edge technology, and holistic patient care.

    The center’s expansion beyond its renowned hair transplantation services—having performed over 30 million hair grafts across 7,000 patients—now encompasses advanced dentistry, aesthetic surgery, and non-surgical treatments. Their dental division offers rapid rehabilitation through implants, veneers, and complete smile design, while their surgical teams perform full-spectrum procedures from head to toe.

    CCEOI’s clinical operations maintain rigorous standards with hospital partnerships for major surgeries, structured postoperative monitoring, and continuous staff training. The institution has invested significantly in technological advancements including AI-guided dental navigation systems, sapphire FUE techniques for hair restoration, laser therapies, and regenerative medicine applications.

    Positioning Mauritius as an emerging medical tourism hub, CCEOI blends international healthcare standards with the island’s luxury hospitality infrastructure. The center caters to global patients through teleconsultation services, dedicated patient ambassadors, customized treatment packages, and partnerships with luxury accommodations. This medical-tourism synergy allows international visitors to combine wellness journeys with confidence-building procedures in an inspiring tropical environment.

    Looking toward future growth, CCEOI identifies collaborative potential with healthcare providers in the United Arab Emirates, signaling the center’s ambition to expand its international reach while maintaining its commitment to clinical excellence and comprehensive patient wellbeing.

  • Foreigners check-in to China for hospital expertise

    Foreigners check-in to China for hospital expertise

    China is experiencing a remarkable transformation in global healthcare perceptions as international patients increasingly choose the country for advanced medical treatment, creating what netizens term ‘reverse medical tourism.’ This trend represents a dramatic shift from just a decade ago when Chinese patients sought care abroad.

    The phenomenon is exemplified by high-profile cases such as Oscar Chalupsky, the former captain of South Africa’s Olympic kayaking team and 12-time world champion. After being diagnosed with high-risk multiple myeloma—a severe bone marrow cancer—six years ago, Chalupsky received discouraging prognoses from medical professionals in South Africa, Portugal, and Germany who deemed his condition ‘difficult to treat or even hopeless.’

    Utilizing artificial intelligence tools including ChatGPT and DeepSeek, Chalupsky identified Shanghai’s Ruijin Hospital as possessing ‘the world’s best hematology department.’ The 62-year-old athlete expressed strong confidence in Chinese healthcare, stating he traveled to Shanghai with high expectations rather than merely to ‘have a try.’

    Following online consultations in November, Ruijin Hospital’s international medical department and hematology team accepted Chalupsky for comprehensive pre-treatment evaluation. His December assessment included whole-body PET-MR imaging, bone marrow biopsy, and T-cell function tests, culminating in a personalized treatment plan centered on CAR-T cell therapy.

    This innovative cancer treatment involves extracting T-cells from the patient’s blood, genetically reprogramming them to target cancer cells, and reinfusing them into the body. Chalupsky’s case illustrates China’s growing expertise in specialized medical areas including proton therapy, targeted pharmaceuticals, and cellular immunotherapies.

    Medical experts attribute this reverse medical tourism trend to China’s unique combination of technological sophistication, clinical experience, treatment efficacy, and cost efficiency. Professor Wang Jian’an, academician of the Chinese Academy of Sciences and medical sector political adviser, notes that China has successfully balanced the global healthcare ‘impossible triangle’ of high quality, affordability, and minimal wait times.

    The pattern extends beyond individual cases to include families like the Vietnamese couple who presented a gratitude banner to Shanghai’s Children’s Hospital of Fudan University in September 2024 after their child received successful treatment for Type 1 spinal muscular atrophy. These developments signal China’s ascending position in the global healthcare landscape, attracting international patients seeking solutions for complex medical conditions that prove challenging elsewhere.

  • UAE’s first robotic-assisted SEEG marks significant step in epilepsy treatment

    UAE’s first robotic-assisted SEEG marks significant step in epilepsy treatment

    Abu Dhabi’s Cleveland Clinic has achieved a medical breakthrough by performing the United Arab Emirates’ inaugural robotic-assisted stereoelectroencephalography (SEEG) procedure, revolutionizing the diagnostic approach to complex epilepsy cases. This advanced technique represents a substantial leap forward in neurological care, building upon the hospital’s previous accomplishment of the nation’s first non-robotic SEEG performed just last year.

    The innovative robotic SEEG methodology replaces traditional frame-based systems that required rigid head frames fixed directly to patients’ skulls—an often uncomfortable and time-intensive process. Instead, this minimally invasive approach utilizes robotic precision to implant delicate electrodes into targeted brain regions, enabling physicians to monitor electrical activity and pinpoint the exact origin of epileptic seizures with unprecedented accuracy.

    Medical executives at Cleveland Clinic Abu Dhabi emphasize that this technological advancement transcends mere equipment acquisition. Dr. Georges-Pascal Haber, Chief Executive Officer, stated: ‘We are providing epilepsy patients with access to safer, more precise diagnostics that can fundamentally transform their treatment pathways. Our investment in neurological innovation enables brain understanding at previously impossible levels.’

    The institution has already successfully completed three procedures since implementing the robotic technology, demonstrating both its clinical viability and growing impact. According to Dr. Florian Roser, Chief Medical Officer and Institute Chief of the Neurological Institute, the technique allows for personalized approaches tailored to each patient’s unique brain anatomy, significantly enhancing diagnostic accuracy while facilitating better-informed treatment strategies.

    This medical milestone reinforces Abu Dhabi’s position at the forefront of minimally invasive neurological treatments and reflects the UAE’s broader commitment to healthcare innovation that prioritizes patient safety, comfort, and superior clinical outcomes.

  • Beijing launches pilot for online pediatric consultations to ease hospital crowding

    Beijing launches pilot for online pediatric consultations to ease hospital crowding

    In a groundbreaking healthcare initiative, China’s National Health Commission has authorized a pioneering one-year pilot program in Beijing that fundamentally transforms pediatric care delivery. This innovative scheme, effective from January through December, marks the nation’s first official endorsement of initial medical consultations for specific childhood conditions via digital platforms.

    The program represents a significant departure from existing regulations that previously confined internet-based medical services exclusively to follow-up appointments after an initial physical examination. This strategic shift aims to harness digital technology to address two critical healthcare challenges: reducing overwhelming congestion at metropolitan hospitals and expanding access to premium medical expertise for patients residing beyond Beijing’s metropolitan area.

    Two premier pediatric institutions—Beijing Children’s Hospital and the Capital Institute of Pediatrics, both under the auspices of Capital Medical University—have been designated to implement this revolutionary program. Their digital medical services will concentrate on three specialized areas: child growth and development metrics, pediatric nutritional guidance, and dermatological conditions affecting children.

    The health commission has established rigorous protocols to ensure the program’s integrity and safety. Participating physicians must demonstrate a minimum of three years of independent clinical practice, and all virtual consultations require the presence of a legal guardian alongside the child patient. Crucially, the guidelines mandate immediate termination of online sessions and referral to physical medical facilities if a child’s condition presents complexities unsuitable for remote diagnosis.

    Enhanced oversight mechanisms covering both medical safety protocols and cybersecurity measures form an integral component of the pilot framework, reflecting the government’s commitment to balancing innovation with patient protection in the digital healthcare landscape.

  • Emirates Hospitals Group announces strategic collaboration with Nice University Hospital, France

    Emirates Hospitals Group announces strategic collaboration with Nice University Hospital, France

    In a landmark move for Middle Eastern healthcare, Emirates Hospitals Group (EHG) has forged a strategic alliance with France’s prestigious Nice University Hospital (Centre Hospitalier Universitaire de Nice). This collaboration, formalized on February 3, 2026, establishes a comprehensive framework for clinical advancement, medical education, and research innovation across the United Arab Emirates and broader region.

    The partnership strategically combines Nice University Hospital’s internationally acclaimed expertise in specialized tertiary care and medical innovation with EHG’s extensive clinical network and growing healthcare ecosystem in the UAE. The collaboration will focus on multidimensional knowledge exchange, clinical cooperation programs, advanced physician training initiatives, and joint academic partnerships designed to elevate regional healthcare standards.

    Christian Schuhmacher, Executive Chairman of EHG’s Board, emphasized the significance of this European partnership: “This collaboration marks a pivotal milestone in our continuous journey to enhance clinical standards and expand our academic capabilities. Aligning with a leading European academic medical center enables us to accelerate knowledge transfer, advance physician development, and ultimately achieve superior patient outcomes.”

    Prosenjit Bhattacharya, Chief Operating Officer of EHG, further elaborated: “This initiative reflects our unwavering commitment to improving patient care through associations with globally recognized centers of excellence. By bringing international clinical expertise directly to UAE patients, we reinforce our strategic vision to establish EHG as the region’s premier platform for advanced healthcare delivery, medical education, and innovative research.”

    Rodolphe Bourret, Chief Executive Officer of Nice University Hospital, expressed enthusiasm for the transcontinental partnership: “We are delighted to collaborate with Emirates Hospitals Group. This alliance creates substantial opportunities for clinical and academic synergy while strengthening the healthcare bridge between European and Middle Eastern medical institutions.”

    The signing ceremony witnessed high-level diplomatic participation, including Dr. Lateefa Al Sada, Head of Consular Services and National Affairs Section, who highlighted the collaboration’s role in strengthening UAE-France bilateral relations. The event was also attended by Hervé Cael, Municipal Councillor and Vice-Chairman of CHU’s Supervisory Board; Christiane Amiel, Deputy Mayor of Nice for International Relations; and Johanna Lerfel, Health Advisor for the Middle East region based at the French Embassy in Saudi Arabia, alongside senior representatives from CHU’s Faculty of Medicine.

  • Second peak of flu season in UAE? Doctors say never too late to get vaccinated

    Second peak of flu season in UAE? Doctors say never too late to get vaccinated

    The United Arab Emirates is confronting an unexpected extension of its influenza season, with medical professionals reporting consistently elevated case numbers throughout January and February rather than the typical decline. Healthcare facilities across the nation are witnessing increased patient volumes presenting with classic flu symptoms including fever, persistent cough, and profound fatigue, particularly affecting family units, elderly citizens, and young children.

    Medical experts clarify that influenza patterns typically unfold in two distinct phases. Influenza A strains typically dominate the initial winter surge between December and January, while Influenza B variants commonly peak during February through April. This biological pattern means individuals who avoided illness during the earlier winter months remain vulnerable to subsequent infection.

    Dr. Rehab Yousuf Al Saadi, Specialist in Family Medicine and Department Head at Saudi German Hospital, Dubai, confirms this atypical pattern: “We’re observing sustained influenza activity in the UAE and globally heading into late January and February, which traditionally represents peak season. Case numbers are significantly higher than anticipated for this period following an initial surge connected to travel and post-holiday social interactions.”

    Physicians attribute this prolonged season to multiple converging factors: cooler temperatures driving indoor congregation, post-travel social gatherings, and insufficient vaccination coverage within communities. The current epidemiological pattern suggests sustained community transmission rather than isolated outbreaks.

    High-risk demographics include adults over 65, children under five, pregnant women, and individuals with pre-existing conditions such as respiratory disorders, cardiac conditions, renal disease, hepatic impairment, or compromised immune systems. Characteristic symptoms comprise high-grade fever (37.8–40°C), extreme exhaustion, sore throat, non-productive cough, myalgia, and rhinorrhea.

    Health authorities emphasize that influenza vaccination remains effective even at this stage of the season. The current vaccine formulation provides protection against both Influenza A and B strains, substantially reducing hospitalization risk and severe complications even when not preventing infection entirely.

    Preventive recommendations include rigorous hand hygiene, respiratory etiquette through cough covering, voluntary isolation when symptomatic, and maintaining robust immune health through balanced nutrition, adequate rest, and proper hydration. Medical attention should be sought immediately for concerning symptoms including respiratory distress, persistent high fever, disorientation, or chest pain and pressure.